Use of HDAC and/or DNMT inhibitors for treatment of ischemic injury
US9393222B2 · kind B2 · utility
0Cited by
1References
24Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Dec 16, 2013 |
| Grant date | Jul 19, 2016 |
| Priority date | — |
| Expiry date | Jun 22, 2034 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P9/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides methods of ameliorating or reducing the extent of ischemic injury, reperfusion injury, and myocardial infarction, by administering an inhibitor of histone deacetylase enzyme (HDAC) or an inhibitor of DNA methyltransferase enzyme (DNMT).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.